CUSTOMER SUPPORT CUSTOMER SUPPORT 022-4603 7236

fund search

Individually analyse each scheme and narrow your options further Every minute detail you need to know about scheme of your choice from asset holdings, best and worst performance and fund returns to competitor analysis; is available in the Fund card.
Using this report card, you can gather vital information regarding the future health of the scheme by analysing the top 10 companies and sectors it invests in. You can also track the fund management’s track record and analyse the philosophy behind scheme’s holdings. All the parameters in the fund card are extremely important and can go a long way in helping you decide which scheme to invest your money.

NAV As on Sep-18-2025

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

Top 10 Holdings
Company
(%)
Sun Pharmaceutical Industries Ltd.
10.96
Apollo Hospitals Enterprise Ltd.
7.65
Cipla Ltd.
7.09
Fortis Healthcare Ltd.
5.15
Abbott India Ltd.
4.82
Lupin Ltd.
4.40
Torrent Pharmaceuticals Ltd.
4.31
Ajanta Pharma Ltd.
3.79
Ipca Laboratories Ltd.
3.61
Anthem Biosciences Ltd.
3.40
Top 10 Sectors
Sectors
(%)
Pharmaceuticals & Drugs
73.57
Hospital & Healthcare Services
21.77
Business Support
1.56
Chemicals
0.96
Asset Allocation
Market Cap Allocation
  Scheme Benchmark ()
Large-Cap 41.67 NA
Mid-Cap 24.72 NA
Small-Cap 28.07 NA

Best and Worst Performance and Ratios

Best Performance in a year
Period Fund (%) Benchmark (%)
Year 23/03/20
to 23/03/21
69.83NA
Worst Performance in a year
Period Fund (%) Benchmark (%)
Year 16/09/21
to 16/09/22
-16.87NA
Ratios
Standard Deviation[%] 17.42
Sharpe Ratio [%] -0.14
Turnover Ratio [%] 0.32
Modified Duration
YTM
Riskometer
very high risk

Investors understand that their principal will be at very high risk

Fund Details
Category
Sector Funds
Inception Date (Regular Plan)
10-Jul-19
Inception Date (Direct Plan)
10-Jul-19
Expense Ratio (Direct Plan) %
1.03
Expense Ratio (Regular Plan) %
2.31
Investing Style
Large Growth
Fund Manager
Dhaval Shah,Dhaval Joshi
Scheme Benchmark
BSE HEALTH CARE - TRI
AUM (Rs. in Cr.)
845.30
Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

Growth Chart of the Scheme Versus Benchmark (SIP value Rs10,000)
Aditya Birla SL Pharma & Healthcare Fund-Reg(G) BSE Health Care - TRI

Performance Comparison with similar Schemes and Benchmark